HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Xu-Chao Zhang Selected Research
Xu-Chao Zhang Research Topics
Disease
52
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 12/2009
36
Neoplasms (Cancer)
01/2024 - 09/2007
30
Lung Neoplasms (Lung Cancer)
01/2023 - 09/2007
11
Adenocarcinoma of Lung
01/2024 - 01/2012
8
Neoplasm Metastasis (Metastasis)
01/2023 - 12/2017
5
Adenocarcinoma
11/2019 - 05/2010
4
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2023 - 12/2017
4
Carcinoma (Carcinomatosis)
01/2022 - 09/2007
3
Disease Progression
01/2023 - 01/2017
2
Sarcoma (Soft Tissue Sarcoma)
10/2021 - 07/2014
2
Carcinogenesis
01/2016 - 08/2012
1
Exanthema (Rash)
12/2023
1
Neuroendocrine Carcinoma
09/2023
1
Albuminuria
02/2023
1
Glomerulonephritis
02/2023
1
IGA Glomerulonephritis (IGA Nephropathy)
02/2023
1
Circulating Neoplastic Cells
01/2023
1
Pleural Effusion (Pleural Effusions)
01/2022
1
Brain Neoplasms (Brain Tumor)
01/2022
1
Melanoma (Melanoma, Malignant)
01/2022
1
Malignant Pleural Effusion
01/2022
1
Carcinoid Tumor (Carcinoid)
12/2021
1
Adenocarcinoma in Situ
11/2019
1
Solitary Pulmonary Nodule
01/2019
1
Urinary Bladder Neoplasms (Bladder Cancer)
12/2015
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2015
1
Lymphatic Metastasis
07/2015
1
Neuroblastoma
07/2014
1
Lymphoma (Lymphomas)
03/2014
1
Neutropenia
06/2012
1
Esophageal Neoplasms (Esophageal Cancer)
01/2012
1
Rare Diseases (Rare Disease)
01/2012
Drug/Important Bio-Agent (IBA)
32
ErbB Receptors (EGF Receptor)
IBA
01/2024 - 12/2009
27
Tyrosine Kinase Inhibitors
IBA
01/2024 - 12/2009
12
Biomarkers (Surrogate Marker)
IBA
01/2023 - 09/2007
10
Immune Checkpoint Inhibitors
IBA
01/2024 - 01/2018
8
Gefitinib (Iressa)
FDA Link
11/2021 - 01/2011
7
Anaplastic Lymphoma Kinase
IBA
01/2023 - 03/2014
6
Proteins (Proteins, Gene)
FDA Link
11/2019 - 09/2007
5
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 08/2011
5
Crizotinib
IBA
11/2018 - 03/2014
3
Cisplatin (Platino)
FDA Link
Generic
01/2023 - 01/2019
3
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2023 - 01/2016
3
Gemcitabine
FDA Link
01/2023 - 03/2010
3
Cell-Free Nucleic Acids
IBA
01/2022 - 01/2016
3
MicroRNAs (MicroRNA)
IBA
01/2021 - 01/2019
3
Messenger RNA (mRNA)
IBA
01/2020 - 09/2007
2
Platinum
IBA
12/2023 - 01/2017
2
pembrolizumab
IBA
12/2023 - 01/2021
2
osimertinib
IBA
01/2022 - 01/2018
2
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
10/2021 - 07/2014
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2021 - 01/2020
2
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
01/2020 - 03/2014
2
B7-H1 Antigen
IBA
11/2019 - 11/2018
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
11/2019 - 12/2014
2
IGF-I-IGFBP-3 complex
FDA Link
06/2017 - 03/2016
2
Phosphotransferases (Kinase)
IBA
03/2014 - 09/2007
2
Paclitaxel (Taxol)
FDA Link
Generic
03/2011 - 01/2011
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2024
1
sintilimab
IBA
12/2023
1
RNA (Ribonucleic Acid)
IBA
10/2023
1
Mutant Proteins (Protein, Mutant)
IBA
09/2023
1
Galactose (Galactopyranose)
FDA Link
Generic
02/2023
1
Immunoglobulin A (IgA)
IBA
02/2023
1
Chimeric Antigen Receptors
IBA
01/2023
1
Tyrosine (L-Tyrosine)
FDA Link
12/2021
1
Irinotecan (Camptosar)
FDA Link
Generic
12/2021
1
icotinib
IBA
12/2021
1
Protons (Proton)
IBA
07/2020
1
sotorasib
IBA
01/2020
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2020
1
Circulating Tumor DNA
IBA
01/2020
1
abivertinib
IBA
05/2019
1
Complementary DNA (cDNA)
IBA
12/2017
1
Ligands
IBA
06/2017
1
cyclo(Arg-Pro) (CI 4)
IBA
12/2015
1
Adiponectin Receptors
IBA
07/2015
1
Carcinoembryonic Antigen
IBA
07/2015
1
Class Ia Phosphatidylinositol 3-Kinase
IBA
07/2014
1
human ERBB2 protein
IBA
07/2014
1
MAP Kinase Kinase 1
IBA
07/2014
1
Tensins
IBA
07/2014
1
70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)
IBA
01/2013
1
Everolimus
FDA Link
11/2012
1
ORALIT (ORS)
IBA
10/2012
1
Extracellular Matrix Proteins
IBA
08/2012
1
Kalinin
IBA
08/2012
1
Bevacizumab (Avastin)
FDA Link
06/2012
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2012
1
Hemoglobins (Hemoglobin)
IBA
06/2012
1
Cytochrome P-450 CYP1A1 (CYP1A1)
IBA
09/2011
Therapy/Procedure
18
Therapeutics
01/2023 - 09/2007
13
Drug Therapy (Chemotherapy)
12/2023 - 03/2010
10
Immunotherapy
01/2024 - 06/2017
3
Precision Medicine
01/2023 - 03/2014
2
Neoadjuvant Therapy
01/2023 - 01/2019
2
Lasers (Laser)
06/2017 - 03/2016
2
Thoracotomy
07/2015 - 05/2010
1
Aftercare (After-Treatment)
01/2021
1
Operative Surgical Procedures
01/2018